Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats

Published:2015-10 Issue: Volume:73 Page:45-56
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Alánová Petra,Husková Zuzana,Kopkan Libor,Sporková Alexandra,Jíchová Šárka,Neckář Jan,Imig John D.,Klevstig Martina,Kolář František,Rami Reddy N.,Falck John R.,Sadowski Janusz,Nishiyama Akira,Kramer Herbert J.,Melenovský Vojtěch,Červenková Lenka,Kujal Petr,Vernerová Zdenka,Červenka Luděk

Funder

Internal Grant Agency of the Ministry of Health of the Czech Republic

Grant Agency of the Charles University

Czech Science Foundation

Ministry of Health of the Czech Republic

USPHS NIH

Robert A. Welch Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference71 articles.

1. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury;Sivaraman;J Cardiovasc Pharmacol Ther,2014

2. Myocardial ischemia–reperfusion injury: a neglected therapeutic target;Hausenloy;J Clin Invest,2013

3. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials;Gerczuk;J Am Coll Cardiol,2012

4. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension;ESH/ESC Task Force for the Management of Arterial Hypertension;J Hypertens,2013

5. Interaction of cardiovascular risk with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning;Ferdinandy;Pharmacol Rev,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inappropriate activation of the renin-angiotensin system improves cardiac tolerance to ischemia/reperfusion injury in rats with late angiotensin II-dependent hypertension;Frontiers in Physiology;2023-06-14

2. Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats;Frontiers in Pharmacology;2022-01-17

3. Increased Endogenous Activity of the Renin-Angiotensin System Reduces Infarct Size in the Rats with Early Angiotensin II-dependent Hypertension which Survive the Acute Ischemia/Reperfusion Injury;Frontiers in Pharmacology;2021-05-28

4. Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats;Clinical Science;2019-04

5. Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats;Frontiers in Pharmacology;2019-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3